Severity of COVID-19 reinfection linked to severity of initial infection
Jul 18, 2024
Individuals who experienced severe initial and first reinfection were older in age and had a higher mortality risk.
Postexposure prophylaxis with nirmatrelvir-ritonavir does not cut COVID-19 Infection
Jul 18, 2024
No significant reduction was seen in the risk for symptomatic SARS-CoV-2 infection with postexposure prophylaxis for five or 10 days.
Long COVID incidence declined over course of pandemic
Jul 23, 2024
The authors say, however, that the risk remained substantial, even among vaccinated persons during the omicron era.
Hospital-onset SARS-CoV-2 infection during omicron linked to morbidity
Jul 15, 2024
Hospital-onset SARS-CoV-2 remained associated with increased morbidity and mortality during the omicron era.
In-hospital delirium increases risk for functional disability, cognitive impairment
Jul 11, 2024
The findings were seen among older adults in the six months following a COVID-19 hospitalization.
Pandemic-era tax credits made healthcare more affordable, but they’re set to expire
Jun 18, 2024
In a success story for Americans seeking affordable healthcare coverage, tax credits put in place during the pandemic helped millions gain health insurance, a new report found. But the credits are set...
Hospital nursing resources tied to COVID-19 survival
Jun 24, 2024
“If all hospitals in the study had superior nursing resources prior to or during the pandemic, models estimate many thousands of deaths among patients hospitalized with COVID-19 could have been avoided,”...
Expert panel develops new definition of long COVID
Jun 11, 2024
A new proposed definition for Long COVID could help patients get the help they need, a new report from the National Academies of Sciences, Engineering and Medicine says.
Residual risk seen for death, postacute sequelae in third year after COVID-19 hospitalization
Jun 13, 2024
The risk for death remains significantly elevated in the third year, as is risk for incident postacute sequelae of COVID-19.
Nirmatrelvir-ritonavir no aid for long COVID symptoms
Jun 10, 2024
The findings based on symptoms at 10 weeks following 15-day course in vaccinated cohort.